femoropopliteal

Giannopoulos Drug-Eluting Stent Figure 1

Original Contribution

Concomitant Drug-Coated Balloon Angioplasty With Bail-Out Use of Eluvia Drug-Eluting Stent: Is There Any Downside to a Double Dose of Paclitaxel?

06/01/2022

Eric A. Secemsky , MD, MSc, RPVI, FACC, FAHA, FSCAI;

Ehrin J. Armstrong , MD, MSc, FACC;

Stefanos Giannopoulos , MD;

The application of 2 distinct and simultaneously applied drug-delivery platforms for the treatment of peripheral artery disease has not been studied. This study investigated the outcomes of femoropopliteal disease treated with drug-coated...

The application of 2 distinct...

06/01/2022

Journal of Invasive Cardiology

Endovascular Techniques

A Tactical Approach to Arterial Access for Critical Limb Ischemia

02/01/2019

George L. Adams , MD, MHS, MBA, FACC, FSCAI;

Vinayak Subramanian , BS;

Rohan Pasi ;

Eric M. Weekman ;

As incidence of diabetes and chronic kidney disease has increased, peripheral arterial disease has emerged as a significant public health challenge worldwide.

As incidence of diabetes and...

02/01/2019

Vascular Disease Management

Review

Should We Routinely Stent the Femoropopliteal Artery? An Interventionalist`s Perspective

11/01/2015

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

Subhash Banerjee , MD, FSCAI;

An overview of the pros and cons of primary stenting of femoropopliteal (FP) arteries vs alternative approaches including provisional stenting following POBA, atherectomy and/or drug-coated balloons.

An overview of the pros and cons...

11/01/2015

Journal of Invasive Cardiology